Sfoglia per Autore
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis
2023 Massironi, S; Gallo, C; Elvevi, A; Stegagnini, M; Coltro, L; Invernizzi, P
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review
2023 Elvevi, A; Laffusa, A; Gallo, C; Invernizzi, P; Massironi, S
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis
2023 Massironi, S; Elvevi, A; Gallo, C; Laffusa, A; Tortorella, A; Invernizzi, P
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis
2023 Cristoferi, L; Porta, M; Bernasconi, D; Leonardi, F; Gerussi, A; Mulinacci, G; Palermo, A; Gallo, C; Scaravaglio, M; Stucchi, E; Maino, C; Ippolito, D; D'Amato, D; Ferreira, C; Nardi, A; Banerjee, R; Valsecchi, M; Antolini, L; Corso, R; Sironi, S; Fagiuoli, S; Invernizzi, P; Carbone, M
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis
2023 Laffusa, A; Ciaccio, A; Elvevi, A; Gallo, C; Ratti, L; Invernizzi, P; Massironi, S
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance
2022 Gallo, C; Invernizzi, P; Massironi, S; Rossi, R; Cavalcoli, F; Barbaro, F; Boskoski, I
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?
2022 Massironi, S; Rossi, R; Milanetto, A; Andreasi, V; Campana, D; Nappo, G; Partelli, S; Gallo, C; Scaravaglio, M; Zerbi, A; Panzuto, F; Pasquali, C; Falconi, M; Invernizzi, P
An update on novel pharmacological agents for primary sclerosing cholangitis
2022 Gallo, C; Howardson, B; Cristoferi, L; Carbone, M; Gershwin, M; Invernizzi, P
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile